We are proposing a large and complex program to discover gene funcfion in Mycobacterium tuberculosis. Core A is dedicated to managing this complexity to ensure that we are able to achieve our goals and to disseminate our findings and the reagents we produce. To accomplish this we will need to manage our internal resources, particularly to provide appropriate access to the technical resources available in the Cores, and permit proper oversight by the NIH. We plan to fulfill these goals in two ways. First, we will facilitate management of the program. Access to resources will be agreed upon by a management committee consisfing of representatives of the projects and cores. We will be aided by the use of a web-based management software suite, customized together with Core E, that will allow us to track the progress with individual genes and to make efficient use of Core technologies. Second, we will provide platforms to exchange ideas and experiences among the investigators and sponsors. We will have regular meetings of the investigators, both physical and virtual, to exchange information. Moreover, program leaders will meet annually with program officers at the NIH. All management will be overseen by the Core Leader with help from an experienced program manager.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI107774-02
Application #
8738907
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Sakatos, Alexandra; Babunovic, Gregory H; Chase, Michael R et al. (2018) Posttranslational modification of a histone-like protein regulates phenotypic resistance to isoniazid in mycobacteria. Sci Adv 4:eaao1478
Lehmann, Johannes; Cheng, Tan-Yun; Aggarwal, Anup et al. (2018) An Antibacterial ?-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis. Angew Chem Int Ed Engl 57:348-353
Gerrick, Elias R; Barbier, Thibault; Chase, Michael R et al. (2018) Small RNA profiling in Mycobacterium tuberculosis identifies MrsI as necessary for an anticipatory iron sparing response. Proc Natl Acad Sci U S A 115:6464-6469
Köster, Stefan; Upadhyay, Sandeep; Chandra, Pallavi et al. (2017) Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA. Proc Natl Acad Sci U S A 114:E8711-E8720
Rock, Jeremy M; Hopkins, Forrest F; Chavez, Alejandro et al. (2017) Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat Microbiol 2:16274
Mishra, Bibhuti B; Lovewell, Rustin R; Olive, Andrew J et al. (2017) Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nat Microbiol 2:17072
DeJesus, Michael A; Gerrick, Elias R; Xu, Weizhen et al. (2017) Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis. MBio 8:
Warner, Digby F; Rock, Jeremy M; Fortune, Sarah M et al. (2017) DNA Replication Fidelity in the Mycobacterium tuberculosis Complex. Adv Exp Med Biol 1019:247-262
Kurthkoti, Krishna; Amin, Hamel; Marakalala, Mohlopheni J et al. (2017) The Capacity of Mycobacterium tuberculosis To Survive Iron Starvation Might Enable It To Persist in Iron-Deprived Microenvironments of Human Granulomas. MBio 8:
Botella, Helene; Vaubourgeix, Julien; Lee, Myung Hee et al. (2017) Mycobacterium tuberculosis protease MarP activates a peptidoglycan hydrolase during acid stress. EMBO J 36:536-548

Showing the most recent 10 out of 33 publications